Cochlear Inkomsten in het verleden
Verleden criteriumcontroles 3/6
Cochlear is de winst gegroeid met een gemiddeld jaarlijks percentage van 22.8%, terwijl de Medical Equipment industrie de winst jaarlijks groeide met 8.3%. De inkomsten zijn gegroeid met een gemiddelde snelheid van 10.6% per jaar. Het rendement op eigen vermogen van Cochlear is 19.4%, en het heeft een nettomarge van 16%.
Belangrijke informatie
22.8%
Groei van de winst
20.5%
Groei van de winst per aandeel
Medical Equipment Groei van de industrie | 5.8% |
Inkomstengroei | 10.6% |
Rendement op eigen vermogen | 19.4% |
Nettomarge | 16.0% |
Volgende winstupdate | 13 Feb 2025 |
Recente prestatie-updates uit het verleden
Recent updates
We Think Shareholders May Consider Being More Generous With Cochlear Limited's (ASX:COH) CEO Compensation Package
Oct 18Cochlear Limited's (ASX:COH) Shareholders Might Be Looking For Exit
Sep 19Cochlear Limited Just Missed EPS By 7.4%: Here's What Analysts Think Will Happen Next
Aug 16Investors Could Be Concerned With Cochlear's (ASX:COH) Returns On Capital
Aug 01Here's Why We Think Cochlear (ASX:COH) Is Well Worth Watching
Jun 08Cochlear (ASX:COH) Might Be Having Difficulty Using Its Capital Effectively
Mar 27Here's Why We Think Cochlear (ASX:COH) Is Well Worth Watching
Feb 21Cochlear (ASX:COH) Might Be Having Difficulty Using Its Capital Effectively
Dec 18Is Cochlear Limited (ASX:COH) Expensive For A Reason? A Look At Its Intrinsic Value
Oct 04Cochlear (ASX:COH) Could Be Struggling To Allocate Capital
Sep 12Some Investors May Be Worried About Cochlear's (ASX:COH) Returns On Capital
Jun 05Cochlear (ASX:COH) Seems To Use Debt Quite Sensibly
Apr 05Some Investors May Be Worried About Cochlear's (ASX:COH) Returns On Capital
Mar 04Is Cochlear (ASX:COH) A Risky Investment?
Dec 19Is Cochlear Limited (ASX:COH) Worth AU$205 Based On Its Intrinsic Value?
Nov 16The Returns On Capital At Cochlear (ASX:COH) Don't Inspire Confidence
Oct 25Should Shareholders Reconsider Cochlear Limited's (ASX:COH) CEO Compensation Package?
Oct 11Cochlear's (ASX:COH) Upcoming Dividend Will Be Larger Than Last Year's
Aug 28Here's Why Cochlear (ASX:COH) Can Manage Its Debt Responsibly
Aug 23The Returns On Capital At Cochlear (ASX:COH) Don't Inspire Confidence
Jul 16A Look At The Fair Value Of Cochlear Limited (ASX:COH)
May 19Capital Allocation Trends At Cochlear (ASX:COH) Aren't Ideal
Apr 09Estimating The Intrinsic Value Of Cochlear Limited (ASX:COH)
Feb 04Capital Allocation Trends At Cochlear (ASX:COH) Aren't Ideal
Dec 24Cochlear (ASX:COH) Seems To Use Debt Quite Sensibly
Oct 30This Is Why We Think Cochlear Limited's (ASX:COH) CEO Might Get A Pay Rise Approved By Shareholders
Oct 12A Look At The Fair Value Of Cochlear Limited (ASX:COH)
Oct 06Returns On Capital Signal Tricky Times Ahead For Cochlear (ASX:COH)
Aug 16Cochlear (ASX:COH) Has A Pretty Healthy Balance Sheet
Jun 24A Look At The Intrinsic Value Of Cochlear Limited (ASX:COH)
May 17There Are Reasons To Feel Uneasy About Cochlear's (ASX:COH) Returns On Capital
Apr 29These 4 Measures Indicate That Cochlear (ASX:COH) Is Using Debt Reasonably Well
Mar 20Opbrengsten en kosten
Hoe Cochlear geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
---|---|---|---|---|
30 Jun 24 | 2,236 | 357 | 898 | 277 |
31 Mar 24 | 2,193 | 354 | 886 | 273 |
31 Dec 23 | 2,149 | 350 | 874 | 270 |
30 Sep 23 | 2,043 | 326 | 842 | 257 |
30 Jun 23 | 1,936 | 301 | 810 | 245 |
31 Mar 23 | 1,824 | 281 | 768 | 230 |
31 Dec 22 | 1,713 | 261 | 725 | 215 |
30 Sep 22 | 1,681 | 275 | 691 | 213 |
30 Jun 22 | 1,648 | 289 | 658 | 211 |
31 Mar 22 | 1,612 | 273 | 628 | 208 |
31 Dec 21 | 1,575 | 257 | 597 | 205 |
30 Sep 21 | 1,536 | 291 | 579 | 200 |
30 Jun 21 | 1,498 | 324 | 560 | 195 |
31 Mar 21 | 1,403 | 82 | 549 | 187 |
31 Dec 20 | 1,308 | -160 | 537 | 180 |
30 Sep 20 | 1,314 | -199 | 550 | 182 |
30 Jun 20 | 1,321 | -238 | 564 | 185 |
31 Mar 20 | 1,400 | 34 | 569 | 188 |
31 Dec 19 | 1,479 | 306 | 574 | 190 |
30 Sep 19 | 1,453 | 291 | 560 | 187 |
30 Jun 19 | 1,427 | 277 | 546 | 184 |
31 Mar 19 | 1,422 | 270 | 535 | 180 |
31 Dec 18 | 1,418 | 264 | 525 | 175 |
30 Sep 18 | 1,391 | 255 | 510 | 172 |
30 Jun 18 | 1,364 | 246 | 494 | 168 |
31 Mar 18 | 1,329 | 234 | 475 | 164 |
31 Dec 17 | 1,294 | 223 | 456 | 160 |
30 Sep 17 | 1,274 | 223 | 444 | 156 |
30 Jun 17 | 1,254 | 224 | 432 | 152 |
31 Mar 17 | 1,218 | 215 | 426 | 149 |
31 Dec 16 | 1,182 | 206 | 420 | 146 |
30 Sep 16 | 1,156 | 198 | 412 | 146 |
30 Jun 16 | 1,131 | 189 | 403 | 145 |
31 Mar 16 | 1,088 | 179 | 383 | 142 |
31 Dec 15 | 1,045 | 168 | 362 | 138 |
30 Sep 15 | 986 | 157 | 341 | 133 |
30 Jun 15 | 926 | 146 | 320 | 128 |
31 Mar 15 | 899 | 145 | 308 | 126 |
31 Dec 14 | 872 | 144 | 296 | 124 |
30 Sep 14 | 839 | 119 | 288 | 126 |
30 Jun 14 | 805 | 94 | 279 | 128 |
31 Mar 14 | 769 | 85 | 267 | 129 |
31 Dec 13 | 732 | 76 | 256 | 130 |
Kwaliteitswinsten: COH heeft hoge kwaliteitsinkomsten.
Groeiende winstmarge: De huidige netto winstmarges (16%) COH } zijn hoger dan vorig jaar (15.5%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: De winst van COH is de afgelopen 5 jaar aanzienlijk gegroeid met 22.8% per jaar.
Versnelling van de groei: De winstgroei van COH over het afgelopen jaar ( 18.7% ) ligt onder het 5-jarig gemiddelde ( 22.8% per jaar).
Winst versus industrie: De winstgroei COH over het afgelopen jaar ( 18.7% ) overtrof de Medical Equipment -sector 18.7%.
Rendement op eigen vermogen
Hoge ROE: Het Rendement op eigen vermogen ( 19.4% ) van COH wordt als laag beschouwd.